Product Name: Human CD20 Antibody (Obinutuzumab, Research Use)
Catalog Number: NBR-0010
Target Name: CD20
Trade Name: Obinutuzumab
Antibody Drug Description: Obinutuzumab, sold under the brand name Gazyva among others, is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD20
Synonyms: MS4A1; Bp35; FMC7; CD20; B1
Target Description: B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes.
Ensembl: ENSG00000156738
Uniprot: P11836